μ opioid and CB1 cannabinoid receptor interactions: Reciprocal inhibition of receptor signaling and neuritogenesis

British Journal of Pharmacology

Volumn 148, Issue 4, 2006, Pages 387-395

  Rios, Carl ^a,b   Gomes, Ivone ^a   Devi, Lakshmi A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

Dimerization; GPCR; Marijuana; Morphine; Neuritogenesis; Oligomerization; THC

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CHEMOKINE RECEPTOR CCR5; DELTA OPIATE RECEPTOR; G PROTEIN COUPLED RECEPTOR; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); KAPPA OPIATE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MU OPIATE RECEPTOR; RENILLA LUCIFERIN 2 MONOOXYGENASE; STAT3 PROTEIN; STEROID RECEPTOR COACTIVATOR 1; YELLOW FLUORESCENT PROTEIN;

ARTICLE; ATTENUATION; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CELL LINE; CONTROLLED STUDY; EMBRYO; ENZYME ASSAY; ENZYME BINDING; HUMAN; HUMAN CELL; HYDROLYSIS; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR SENSITIVITY; RENILLA; SIGNAL TRANSDUCTION;

CELLS, CULTURED; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; NEURITES; PHOSPHORYLATION; RECEPTOR, CANNABINOID, CB1; RECEPTORS, OPIOID, MU; SIGNAL TRANSDUCTION;

EID: 33745085564     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706757     Document Type: Article

References (39)

1. ANGERS, S., SALAHPOUR, A. & BOUVIER, M. (2002). Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu. Rev. Pharmacol. Toxicol., 42, 409-435.
2. BALLESTA, J.J. & ORTS, A. (1992). Interaction of opioid drugs with human platelet alpha 2-adrenoceptors. Eur. J. Pharmacol., 227, 349-351.
3. BANÈRES, J.-L. & PARELLO, J. (2003). Structure-based analysis of GPCR function: evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein. J. Mol. Biol., 329, 815-829.
4. CICHEWICZ, D.L. (2004). Synergistic interactions between cannabinoid and opioid analgesics. Life Sci., 74, 1317-1324.
5. DHAWAN, B.N., CESSELIN, F., RAGHUBIR, R., REISINE, T., BRADLEY, P.B., PORTOGHESE, P.S. & HAMON, M. (1996). International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol. Rev., 48, 567-592.
6. FILIPEK, S., KRZYSKO, K.A., FOTIADIS, D., LIANG, Y., SAPERSTEIN, D.A., ENGEL, A. & PALCZEWSKI, K. (2004). A concept for G protein activation by G protein-coupled receptor dimers: the transducin/rhodopsin interface. Photochem. Photobiol. Sci., 3, 628-638.
7. FOTIADIS, D., LIANG, Y., FILIPEK, S., SAPERSTEIN, D.A., ENGEL, A. & PALCZEWSKI, K. (2004). The G protein-coupled receptor rhodopsin in the native membrane. FEBS Lett., 564, 281-288.
8. FRICKER, A.D., RIOS, C., DEVI, L.A. & GOMES, I. (2005). Serotonin receptor activation leads to neurite outgrowth and neuronal survival. Brain Res. Mol. Brain Res., 138, 228-235.
9. GASSMANN, M., SHABAN, H., VIGOT, R., SANSIG, G., HALLER, C., BARBIERI, S., HUMEAU, Y., SCHULER, V., MULLER, M., KINZEL, B., KLEBS, K., SCHMUTZ, M., FROESTL, F., HEID, J., KELLY, P.H., GENTRY, C., JATON, A.L., VAN DER PUTTEN, H., MOMBEREAU, C., LECOURTIER, L., MOSBACHER, J., CRYAN, J.F., FRITSCHY, J.M., LUTHI, A., KAUPMANN, K. & BETTLER, B. (2004). Redistribution of GABAB(1) protein and atypical GABAB responses in GABAB(2)-deficient mice. J. Neurosci., 24, 6086-6097.
10. GHOZLAND, S., MATTHES, H.W.D., SIMONIN, F., FILLIOL, D., KIEFFER, B.L. & MALDONADO, R. (2002). Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors. J. Neurosci., 22, 1146-1154.
11. GOMES, I., FILIPOVSKA, J., JORDAN, B.A. & DEVI, L.A. (2003). Oligomerization of opioid receptors. Methods, 27, 358-365.
12. GOMES, I., GUPTA, A., FILIPOVSKA, J., SZETO, H.H., PINTAR, J.E. & DEVI, L.A. (2004). A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia. Proc. Natl. Acad. Sci. U.S.A., 101, 5135-5139.
13. GOMES, I., GUPTA, A., SINGH, S.P. & SHARMA, S.K. (1999). Monoclonal antibody to the delta opioid receptor acts as an agonist in dual regulation of adenylate cyclase in NG108-15 cells. FEBS Lett., 456, 126-130.
14. GUO, W., SHI, L. & JAVITCH, J.A. (2003). The fourth transmembrane segment forms the interface of the dopamine D2 receptor homodimer. J. Biol. Chem., 278, 4385-4388.
15. GUO, W., SHI, L., FILIZOLA, M., WEINSTEIN, H. & JAVITCH, J.A. (2005). From The Cover: Crosstalk in G protein-coupled receptors: Changes at the transmembrane homodimer interface determine activation. Proc. Natl. Acad. Sci. U.S.A., 102, 17495-17500.
16. HE, J.C., GOMES, I., NGUYEN, T., JAYARAM, G., RAM, P.T., DEVI, L.A. & IYENGAR, R. (2005). The Galpha o/i coupled cannabinoid receptor mediated neurite outgrowth involves Rap regulation of Src and Stat3. J. Biol. Chem., 280, 33426-33434.
17. HOCHHAUS, G., YU, V.C. & WOLFGANG, S. (1986). Delta opioid receptors in human neuroblastoma cell lines. Brain Research, 382, 327-331.
18. HOWLETT, A.C., BARTH, F., BONNER, T.I., CABRAL, G., CASELLAS, P., DEVANE, W.A., FELDER, C.C., HERKENHAM, M., MACKIE, K., MARTIN, B.R., MECHOULAM, R. & PERTWEE, R.G. (2002). International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev., 54, 161-202.
19. JORDAN, B.A., GOMES, I., RIOS, C., FILIPOVSKA, J. & DEVI, L.A. (2003). Functional interactions between mu opioid and alpha 2A-adrenergic receptors. Mol. Pharmacol., 64, 1317-1324.
20. JORDAN, B.A., TRAPAIDZE, N., GOMES, I., NIVARTHI, R. & DEVI, L.A. (2001). Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. Proc. Natl. Acad. Sci. U.S.A., 98, 343-348.
21. JORDAN, J.D., HE, J.C., EUNGDAMRONG, N.J., GOMES, I., ALI, W., NGUYEN, T., BIVONA, T.G., PHILIPS, M.R., DEVI, L.A. & IYENGAR, R. (2005). Cannabinoid receptor-induced neurite outgrowth is mediated by Rap1 activation through G(alpha)o/i-triggered proteasomal degradation of Rap1GAPII. J. Biol. Chem., 280, 11413-11421.
22. KNIAZEFF, J., BESSIS, A.S., MAUREL, D., ANSANAY, H., PREZEAU, L. & PIN, J.P. (2004). Closed state of both binding domains of homodimeric mGlu receptors is required for full activity. Nat. Struct. Mol. Biol., 11, 706-713.
23. KUNISHIMA, N., SHIMADA, Y., TSUJI, Y., SATO, T., YAMAMOTO, M., KUMASAKA, T., NAKANISHI, S., JINGAMI, H. & MORIKAWA, K. (2000). Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature, 407, 971-977.
24. LEDENT, C., VALVERDE, O., COSSU, G., PETITET, F., AUBERT, J.-F., BESLOT, F., BOHME, G.A., IMPERATO, A., PEDRAZZINI, T., ROQUES, B.P., VASSART, G., FRATTA, W. & PERMENTIER, M. (1999). Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science, 283, 401-404.
25. MANZANARES, J., CORCHERO, J., ROMERO, J., FERNANDEZ-RUIZ, J.J., RAMOS, J.A. & FUENTES, J.A. (1999). Pharmacological and biochemical interactions between opioids and cannabinoids. Trends Pharmacol. Sci., 20, 287-294.
26. MAY, L.T. & CHRISTOPOULOS, A. (2003). Allosteric modulators of G-protein-coupled receptors. Curr. Opin. Pharmacol., 3, 551-556.
27. NAIR, V.D. & SEALFON, S.C. (2003). Agonist-specific transactivation of phosphoinositide 3-kinase signaling pathway mediated by the dopamine D2 receptor. J. Biol. Chem., 278, 47053-47061.
28. NAIR, V.D., OLANOW, C.W. & SEALFON, S.C. (2003). Activation of phosphoinositide 3-kinase by D2 receptor prevents apoptosis in dopaminergic cell lines. Biochem. J., 373, 25-32.
29. PICKEL, V.M., CHAN, J., KASH, T.L., RODRIGUEZ, J.J. & MACKIE, K. (2004). Compartment-specific localization of cannabinoid 1 (CB1) and mu-opioid receptors in rat nucleus accumbens. Neuroscience, 127, 101-112.
30. RIOS, C., GOMES, I. & DEVI, L.A. (2004). Interactions between delta opioid receptors and alpha-adrenoceptors. Clin. Exp. Pharmacol. Physiol., 31, 833-836.
31. RIOS, C.D., JORDAN, B.A., GOMES, I. & DEVI, L.A. (2001). G-protein-coupled receptor dimerization: modulation of receptor function. Pharmacol. Ther., 92, 71-87.
32. RODRIGUEZ, J.J., MACKIE, K. & PICKEL, V.M. (2001). Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus. J. Neurosci., 21, 823-833.
33. SALIO, C., FISCHER, J., FRANZONI, M.F., MACKIE, K., KANEKO, T. & CONRATH, M. (2001). CB1-cannabinoid and mu-opioid receptor co-localization on postsynaptic target in the rat dorsal horn. NeuroReport, 12, 3689-3692.
34. VASQUEZ, C. & LEWIS, D.L. (1999). The CB1 cannabinoid receptor can sequester G proteins, making them unavailable to couple to other receptors. J. Neurosci., 19, 9271-9280.
35. VAYSSE, P.J., GARDNER, E.L. & ZUKIN, R.S. (1987). Modulation of rat brain opioid receptors by cannabinoids. J. Pharmacol. Exp. Ther., 241, 534-539.
36. WAGER-MILLER, J., WESTENBROEK, R. & MACKIE, K. (2002). Dimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an example. Chem. Phys. Lipids, 121, 83-89.
37. WHITE, J.H., WISE, A., MAIN, M.J., GREEN, A., FRASER, N.J., DISNEY, G.H., BARNES, A.A., EMSON, P., FOORD, S.M. & MARSHALL, F.H. (1998). Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature, 396, 679-682.
38. XIAO, J. & LIU, Y. (2003). Differential roles of ERK and JNK in early and late stages of neuritogenesis: a study in a novel PC12 model system. J. Neurochem., 86, 1516-1523.
39. ZHAO, W.Q., ALKON, D.L. & MA, W. (2003). c-Src protein tyrosine kinase activity is required for muscarinic receptor-mediated DNA synthesis and neurogenesis via ERK1/2 and c-AMP-responsive element-binding protein signaling in neural precursor cells. J. Neurosci. Res., 72, 334-342.